References
- Hatch FT Lindgren FT Adamson GL Jensen LC Wong AW Levy RI Quantitative agarose gel electrophoresis of plasma lipoproteins: a simple technique and two methods for standardization J Lab Clin Med 1973 Jun 81 6 946 60
- Gofman JW Young W Tandy R Ischemic heart disease, atherosclerosis, and longevity Circulation 1966 Oct 34 4 679 97
- Burstein M Scholnick HR Morfin R Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions J Lipid Res 1970 Nov 11 6 583 95
- Rudel LL Lee JA Morris MD Felts JM Characterization of plasma lipoproteins separated and purified by agarose-column chromatography Biochem J 1974 Apr 139 1 89 95
- Foreman JR Karlin JB Edelstein C Juhn DJ Rubenstein AH Scanu AM Fractionation of human serum lipoproteins by single-spin gradient ultracentrifugation: quantification of apolipoproteins B and A-1 and lipid components J Lipid Res 1977 Nov 18 6 759 67
- Wilcox HG Davis DC Heimberg M The isolation of lipoproteins from human plasma by ultracentrifugation in zonal rotors J Lipid Res 1971 Mar 12 2 160 72
- Patsch JR Sailer S Kostner G Sandhofer F Holasek A Braunsteiner H Separation of the main lipoprotein density classes from human plasma by rate-zonal ultracentrifugation J Lipid Res 1974 Jul 15 4 356 66
- Havel RJ Eder HA Bragdon JH The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum J Clin Invest 1955 Sep 34 9 1345 53
- Friedewald WT Levy RI Fredrickson DS Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 1972 Jun 18 6 499 502
- Martin SS Blaha MJ Elshazly MB Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile JAMA 2013 Nov 20 310 19 2061 8
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease JAMA 1984 Jan 20 251 3 351 64
- Endo A The discovery and development of HMG-CoA reductase inhibitors J Lipid Res 1992 Nov 33 11 1569 82
- Brown AG Smale TC King TJ Hasenkamp R Thompson RH Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum J Chem Soc Perkin 1 1976 11 1165 70
- Downs JR Clearfield M Weis S Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study JAMA 1998 May 27 279 20 1615 22
- Shepherd J Cobbe SM Ford I Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 1995 Nov 16 333 20 1301 7
- MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamin supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience Eur Heart J 1999 May 20 10 725 41
- Garcia-Calvo M Lisnock J Bull HG The target of ezetimibe is Niemann-Pick C1-Like 1 (NPC1L1) Proc Natl Acad Sci U S A 2005 Jun 7 102 23 8132 7
- Raal FJ Santos RD Blom DJ Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial Lancet 2010 Mar 20 375 9719 998 1006
- Cuchel M Bloedon LT Szapary PO Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia N Engl J Med 2007 Jan 11 356 2 148 56
- Cuchel M Meagher EA du Toit Theron H Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study Lancet 2013 Jan 5 381 9860 40 6
- Sattar N Preiss D Murray HM Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials Lancet 2010 Feb 27 375 9716 735 42
- Frick MH Elo O Haapa K Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease N Engl J Med 1987 Nov 12 317 20 1237 45
- Manninen V Elo MO Frick MH Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study JAMA 1988 Aug 5 260 5 641 51
- Robins SJ Collins D Wittes JT .; VA-HIT Study Group Veterans Affairs High-Density Lipoprotein Intervention Trial. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial JAMA 2001 Mar 28 285 12 1585 91
-
Hartung
GH
Foreyt
JP
Mitchell
RE
Mitchell
JG
Reeves
RS
Gotto
AM
Jr Effect of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men JAMA 1983 Feb 11 249 6 747 50 - Ronksley PE Brien SE Turner BJ Mukamal KJ Ghali WA Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis BMJ 2011 Feb 22 342 d671
- Thun MJ Peto R Lopez AD Alcohol consumption and mortality among middle-aged and elderly U.S. adults N Engl J Med 1997 Dec 11 337 24 1705 14
- Langer RD Criqui MH Reed DM Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease Circulation 1992 Mar 85 3 910 5
- Nilsson NO Belfrage P Effects of acetate, acetaldehyde, and ethanol on lipolysis in isolated rat adipocytes J Lipid Res 1978 Aug 19 6 737 411
- Abramson EA Arky RA Acute antilipolytic effects of ethyl alcohol and acetate in man J Lab Clin Med 1968 Jul 72 1 105 17
- Pownall HJ Dietary ethanol is associated with reduced lipolysis of intestinally derived lipoproteins J Lipid Res 1994 Dec 35 12 2105 13
- Ge H Li X Weiszmann J Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids Endocrinology 2008 Sep 149 9 4519 26
- Zhong S Sharp DS Grove JS Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels J Clin Invest 1996 Jun 15 97 12 2917 23
- Rosenson RS CETP inhibition improves the lipid profile but has no effect on clinical cardiovascular outcomes in high-risk patients Evid Based Med 2017 Oct 22 5 184 5
- The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research group JAMA 1972 May 15 220 7 996 1008
- Boden WE Probstfield JL Anderson T .; AIM-HIGH Investigators Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 2011 Dec 15 365 24 2255 67
- Landray MJ Haynes R Hopewell JC Effects of extended-release niacin with laropiprant in high-risk patients N Engl J Med 2014 Jul 17 371 3 203 12
- Ginsberg HN The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid trial: what we learn from subgroup analyses Diabetes Care 2011 May 34 Suppl 2 S107 8
- Nicholls SJ Andrews J Kastelein JJP Effect of Serial Infusions of CER-001, a Pre-β High-Density Lipoprotein Mimetic, on Coronary Atherosclerosis in Patients Following Acute Coronary Syndromes in the CER-001 Atherosclerosis Regression Acute Coronary Syndrome Trial: A Randomized Clinical Trial JAMA Cardiol. 2018 Jul 25
- Nicholls SJ Puri R Ballantyne CM Effect of Infusion of High-Density Lipoprotein Mimetic Containing Recombinant Apolipoprotein A-I Milano on Coronary Disease in Patients With an Acute Coronary Syndrome in the MILANO-PILOT Trial: A Randomized Clinical Trial JAMA Cardiol 2018 Sep 1 3 9 806 814
- Haase CL Tybjærg-Hansen A Grande P Frikke-Schmidt R Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease J Clin Endocrinol Metab 2010 Dec 95 12 E500 10
- Voight BF Peloso GM Orho-Melander M Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study Lancet 2012 Aug 11 380 9841 572 80
- Magnus P Bakke E Hoff DA Controlling for high-density lipoprotein cholesterol does not affect the magnitude of the relationship between alcohol and coronary heart disease Circulation 2011 Nov 22 124 21 2296 302
- Ross R Glomset JA Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis Science 1973 Jun 29 180 4093 1332 9
- Rader DJ Tall AR The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis? Nat Med. 2012 Sep 18 9 1344 6
-
Gillard
BK
Bassett
GR
Gotto
AM
Jr Rosales C Pownall HJ Scavenger receptor B1 (SR-B1) profoundly excludes high density lipoprotein (HDL) apolipoprotein AII as it nibbles HDL-cholesteryl ester J Biol Chem 2017 May 26 292 21 8864 73 - Khera AV Cuchel M de la Llera-Moya M Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis N Engl J Med 2011 Jan 13 364 2 127 35
- Rohatgi A Khera A Berry JD HDL cholesterol efflux capacity and incident cardiovascular events N Engl J Med 2014 Dec 18 371 25 2383 93
- Krause BR Remaley AT Reconstituted HDL for the acute treatment of acute coronary syndrome Curr Opin Lipidol 2013 Dec 24 6 480 6
- Mendez AJ Anantharamaiah GM Segrest JP Oram JF Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol J Clin Invest 1994 Oct 94 4 1698 705
-
Xu
B
Gillard
BK
Gotto
AM
Jr Rosales C Pownall HJ ABCA1-Derived Nascent High-Density Lipoprotein-Apolipoprotein AI and Lipids Metabolically Segregate Arterioscler Thromb Vasc Biol 2017 Dec 37 12 2260 70 - Ji Y Wang N Ramakrishnan R Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile J Biol Chem 1999 Nov 19 274 47 33398 402
- Schwartz CC VandenBroek JM Cooper PS Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans J Lipid Res 2004 Sep 45 9 1594 607
- Hamer M O'Donovan G Stamatakis E High-Density Lipoprotein Cholesterol and Mortality: Too Much of a Good Thing? Arterioscler Thromb Vasc Biol. 2018 Mar 38 3 669 72
- Ko DT Alter DA Guo H High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in Individuals Without Previous Cardiovascular Conditions: The CANHEART Study J Am Coll Cardiol 2016 Nov 8 68 19 2073 83
- Bowe B Xie Y Xian H Balasubramanian S Zayed MA Al-Aly Z High Density Lipoprotein Cholesterol and the Risk of All-Cause Mortality among U.S. Veterans Clin J Am Soc Nephrol 2016 Oct 7 11 10 1784 93
- Madsen CM Varbo A Nordestgaard BG Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies Eur Heart J 2017 Aug 21 38 32 2478 86
- Madsen CM Nordestgaard BG Is It Time for New Thinking About High-Density Lipoprotein? Arterioscler Thromb Vasc Biol. 2018 Mar 38 3 484 6
-
Picardo
M
Massey
JB
Kuhn
DE
Gotto
AM
Jr Gianturco SH Pownall HJ Partially reassembled high density lipoproteins. Effects on cholesterol flux, synthesis, and esterification in normal human skin fibroblasts Arteriosclerosis 1986 Jul–Aug 6 4 434 41
DOI: https://doi.org/10.14797/mdcj-15-1-9 | Journal eISSN: 1947-6108
Language: English
Page range: 9 - 15
Published on: Jan 1, 2019
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2019 Henry J. Pownall, Jr. Gotto, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.